What Challenges Exist in Targeting Fusion Proteins?
Despite their promise, targeting fusion proteins presents several challenges. Resistance to therapy can develop, often through secondary mutations in the fusion protein. Additionally, not all fusion proteins have a suitable drug target, and some may have complex effects on cellular pathways that complicate treatment. There is also the challenge of accurately identifying the presence of fusion proteins in patients to guide therapy.
